A Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers

NCT02587442 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Radiation Syndrome

Interventions

DRUG: RadProtect®

Sponsor

Original BioMedicals Co. Ltd.